Development
Sentry Biopharma abatement
Summary not yet generated for this topic.
Community sentiment
Supportive (2)
At a glance
- Public comments
- 2
- Last 30 days
- 2
Discussed at 1 meeting in the last 60 days; most recently Nov 9, 2026.
Public comments (2)
SupportivePhil WagnerNov 9, 2026
EDC president pitched the abatement, citing $11.5 million investment, 23 new jobs above the county's wage standard, and cold-chain pharma capability as a recruiting tool.
Council — November 9, 2026 · 2:42 →SupportiveTim MitchellNov 9, 2026
Company CEO described 20 years in operation, 222 pharma clients, the Columbus site's tornado/flood advantages, and the need for a second power feed from Duke.
Council — November 9, 2026 · 8:00 →